IGFBP7 and atherosclerosis: Our analysis demonstrates that the editing of IGFBP7 is markedly increased with cardiac or vascular injury (increases in LV editing from 16% to 26% and 26% to 34% in ischemic cardiomyopathy and atherosclerosis, respectively).